Down On The Bayou: Louisiana's Science Citations Slump

For scientists, publishing in great quantity can be a sign of productivity or of striving to please the "paper counters" who sometimes serve on grant and promotion committees. Mere output, for individuals, is not always the mark of achievement—and the same goes for states. The Scientist recently surveyed the scientific output of America's 50 states and the District of Columbia and found Illinois, Maryland, and Louisiana the big winners for the period 1979-1987. These three boosted their sh

Written byDavid Pendlebury
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Scientist recently surveyed the scientific output of America's 50 states and the District of Columbia and found Illinois, Maryland, and Louisiana the big winners for the period 1979-1987. These three boosted their share of scientific papers published in over 3,000 top-flight scientific journals (those indexed in the Institute for Scientific Information's Science Citation Index) by 1.5%, .9%, and .8%, respectively (see The Scientist, July 25, page 18). Texas and Delaware increased their shares by .5%, Massachusetts, Pennsylvania, Alabama, Washington, and Arizona boosted theirs by +.4%, and California and Florida increased theirs by +.3%.

Papers from Maryland, the home of Johns Hopkins and the National Institutes of Health, were consistently cited at the highest levels during the entire period—in the range of 1.36 to 1.41 times the average for all U.S. papers (1.0). Besides its high quality, Maryland's scientific output compares favorably to the national average because of the predominance ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies